Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441610
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2007-02-28
Brief Title:
An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis